AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17156222
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg administered intravenously 30 min before the end of surgery
Trial: 10501408
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of antioxidants, niacin, and warfarin
Trial: 1681430
Drug: Isoniazid (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoniazid (up to 1,200 mg daily) with 100 mg pyridoxine for four weeks
Trial: 30328031
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg melatonin once a day
Trial: 20976430
Drug: Home visiting
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home visiting program 'Pro Kind' (treatment group)
Trial: 9851759
Drug: Testosterone administration
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone administration (300 mg, im, every 3 weeks for 6 months)
Trial: 26869247
Drug: 2 mg/2
RxNorm normalized name: risperidone 2 mg/2 mL ORAL SYRINGE (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/2 mg buprenorphine/samidorphan
Trial: 26869247
Drug: 8 mg/8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg/8 mg buprenorphine/samidorphan
Trial: 22302908
Drug: Gabapentin (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (oral dose before surgery)
Trial: 100808
Drug: Methamphetamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methamphetamine (10 mg)
Trial: 15936062
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Methamphetamine (10 mg) and Zolpidem (10 mg)
Trial: 10543415
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg medrogestone (Prothil)
Trial: 6352020
Drug: Weekly high‐dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly high‐dose asparaginase
Trial: 6352020
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (vincristine, prednisone, doxorubicin)
Trial: 27049778
Drug: Active Nonoperative
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active Nonoperative Therapy (NO) with low-dose neuromodulator (amitriptyline 25 mg/day)
Trial: 18709235
Drug: Daily iron
RxNorm normalized name: Walgreens Multivitamin One Daily Iron-Free Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily iron supplementation (12.5mg Fe/day)
Trial: 18709235
Drug: Weekly iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly iron supplementation (25mg Fe/week)
Trial: 15957672
Drug: Individual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual treatment for female alcoholics
Trial: 15957672
Drug: Couple treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Couple treatment for female alcoholics
Trial: 8394861
Drug: Sodium stibogluconate
RxNorm normalized name: sodium stibogluconate
DrugBank: Sodium stibogluconate (DB05630)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium stibogluconate (Sbv) at 20 mg/kg/day for 30 days (group S)
Trial: 8394861
Drug: Sodium stibogluconate
RxNorm normalized name: sodium stibogluconate
DrugBank: Sodium stibogluconate (DB05630)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium stibogluconate (Sbv) at 20 mg/kg/day plus aminosidine at 15 mg/kg/day for 17 days (group AS)
Trial: 3089361
Drug: Nystatin suspension
RxNorm normalized name: Nystatin
DrugBank: Nystatin (DB00646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nystatin suspension or pastilles (new formulation)
Trial: 3089361
Drug: Concomitant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant treatment of dentures
Trial: 18280835
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment, sc 66 µg/Kg/d
Trial: 17128839
Drug: Intramuscular (i.m.)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (i.m.) vaccination (40 microgram, 2 ml)
Trial: 17128839
Drug: Subcutaneous (s.c.)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (s.c.) vaccination (10 microgram, 0.5 ml)
Trial: 17128839
Drug: Intradermal (i.d.)
RxNorm normalized name: IOBENGUANE I 123
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal (i.d.) vaccination (10 microgram, 0.5 ml)
Trial: 31178989
Drug: Occupational Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational Therapy (OT) + Virtual Reality (VR)
Trial: 24597840
Drug: Luseogliflozin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luseogliflozin (all doses)
Trial: 19049846
Drug: Enoxaparin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (1 mg/kg)
Trial: 16366812
Drug: Adolescent Drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adolescent Drug Abuse Diagnosis Scale self-report measure
Trial: 12163983
Drug: Mg(2+) supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mg(2+) supplementation (10 mmol for 3 days, 20 mmol for 3 days, 30 mmol for 14 days)
Trial: 12163983
Drug: Mg(2+) supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mg(2+) supplementation
Trial: 9588417
Drug: Intraaortic balloon
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraaortic balloon counterpulsation (IABC) with 20 ml inflation volume
Trial: 9588417
Drug: Intraaortic balloon
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraaortic balloon counterpulsation (IABC) with 40 ml inflation volume
Trial: 8560129
Drug: Temazepam 15-30
RxNorm normalized name: temazepam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam 15-30 mg/day
Trial: 8560129
Drug: Placebo or
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo or behavior therapy
Trial: 22659250
Drug: T-gel
RxNorm normalized name: Neutrogena T-Gel Conditioner
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T-gel
Trial: 22659250
Drug: T-gel +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T-gel + DMPA
Trial: 22659250
Drug: T-gel +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T-gel + dutasteride
Trial: 20084316
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (weekly sessions for twelve weeks)
Trial: 15381386
Drug: Clopidogrel treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel treatment (75 mg/day; 7 days)
Trial: 11432884
Drug: Initial lumbar
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial lumbar puncture and intrathecal chemotherapy performed after 1 week of prednisolone sensitivity testing (day 8).
Trial: 7983234
Drug: 0.6 mg
RxNorm normalized name: thymol 0.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg nitroglycerin (NTG) sublingually
Trial: 2590601
Drug: Phentolamine 5
RxNorm normalized name: phentolamine 5 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phentolamine 5 mg i.v.
Trial: 31589615
Drug: Alpha-adrenergic blockers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-adrenergic blockers
Trial: 25766261
Drug: Glucose-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-based therapy
Trial: 25766261
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of glucose-sparing regimen vs glucose-based therapy
Trial: 10740421
Drug: Leaving patients
RxNorm normalized name: digitalis leaves
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leaving patients with atrial fibrillation (AF) treated by rate control and antithrombotic treatment
Trial: 10684783
Drug: Alcohol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.5 g/kg)
Trial: 7098380
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg intravenous (IV) propranolol
Trial: 7098380
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg oral propranolol
Trial: 7098380
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg oral propranolol (multiple doses every 12 h)
Trial: 7098380
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg oral propranolol (single dose)
Trial: 25934242
Drug: Lumboperitoneal shunt
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lumboperitoneal shunt surgery (immediate treatment group)
Trial: 25934242
Drug: Postponed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postponed treatment group (surgery postponed for 3 months)
Trial: 20622199
Drug: Golimumab plus
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Golimumab plus methotrexate (background therapy) every 4 weeks through week 52
Trial: 20622199
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus methotrexate (background therapy) every 4 weeks through week 52
Trial: 11504165
Drug: Acebutolol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (400 mg once a day)
Trial: 7934974
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy (continuous intravenous infusion)
Trial: 29146648
Drug: E-PsEYE e-mental
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: E-PsEYE e-mental health intervention based on cognitive-behavioral therapy (CBT) with nine modules delivered in a stepped-care model.
Trial: 26592061
Drug: Text messaging
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text messaging intervention (12 weekly messages)
Trial: 23440247
Drug: FF/VI 100/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF/VI 100/25 µg once daily
Trial: 23440247
Drug: FF/VI 200/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF/VI 200/25 µg once daily
Trial: 23440247
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 500 µg twice daily
Trial: 15224654
Drug: Intra-uterine system
RxNorm normalized name: gentamicin
DrugBank: Gentamicin (DB00798)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-uterine system releasing 10 micrograms/day levonorgestrel and 2 mg oral estradiol (trial 1)
Trial: 15224654
Drug: Intrauterine system
RxNorm normalized name: Intrauterine System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrauterine system releasing 20 micrograms/day levonorgestrel and 2 mg estradiol (trial 2)
Trial: 15224654
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 1 mg norethisterone acetate and 2 mg estradiol (trial 2)
Trial: 9203809
Drug: Imidazole salycilate
RxNorm normalized name: imidazole salicylate
DrugBank: Imidazole salicylate (DB13860)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidazole salycilate (IS) 1,500 mg acute dose
Trial: 9203809
Drug: Imidazole salycilate
RxNorm normalized name: imidazole salicylate
DrugBank: Imidazole salicylate (DB13860)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidazole salycilate (IS) 750 mg t.i.d. for 15 days
Trial: 9203809
Drug: Imidazole salycilate
RxNorm normalized name: imidazole salicylate
DrugBank: Imidazole salicylate (DB13860)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidazole salycilate (IS) 750 mg t.i.d. for 30 days
Trial: 2735733
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg per day of trimetazidine (TMZ)
Trial: 30674586
Drug: Inhaled lipopolysaccharide
RxNorm normalized name: sulfated mucopolysaccharides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled lipopolysaccharide (LPS) 50 µg
Trial: 21693044
Drug: Hand therapy
RxNorm normalized name: Octinoxate 3.00 mL in 75 mL / Avobenzone 1.5 mL in 75 mL TOPICAL CREAM [Botanics Daily Hand Therapy Sunscreen SPF 10]
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hand therapy with night-splinting
Trial: 21693044
Drug: Hand therapy
RxNorm normalized name: Octinoxate 3.00 mL in 75 mL / Avobenzone 1.5 mL in 75 mL TOPICAL CREAM [Botanics Daily Hand Therapy Sunscreen SPF 10]
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hand therapy only
Trial: 16456637
Drug: 0.2 percent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 percent glycerine trinitrate ointment applied three times daily at the anal margin for eight weeks (Group A)
Trial: 16456637
Drug: 20 units
RxNorm normalized name: Omnipod GO 20 Units/Day Pods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 units Botulinum toxin A injection into the internal anal sphincter on each side of the anterior midline (Group B)
Trial: 25635420
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg intrathecal hyperbaric bupivacaine with 2.5 μg sufentanil
Trial: 25635420
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg intrathecal hyperbaric bupivacaine with 2.5 μg sufentanil
Trial: 25635420
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg intrathecal hyperbaric bupivacaine with 2.5 μg sufentanil
Trial: 25635420
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg intrathecal hyperbaric bupivacaine with 2.5 μg sufentanil
Trial: 24996507
Drug: ω‐3 PUFAs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ω‐3 PUFAs (eicosapentaenoic acid 2g/day and docosahexaenoic acid 1g/day) + α‐LA 300 mg/day
Trial: 15179406
Drug: ABT-773 450
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-773 450 mg in CYP3A5-negative subjects (n = 9)
Trial: 15179406
Drug: ABT-773 450
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-773 450 mg in CYP3A5-positive subjects (n = 8)
Trial: 15179406
Drug: ABT-773 150
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-773 150 mg or 300 mg